title: Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke.
authors: Mayo Clinic College of Medicine, Mayo Clinic, Jacksonville, Florida 32224, USA. fletcher.gerald@mayo.edu
authors: Gerald F
authors: GF
authors: Fletcher
authors: Vincent
authors: V
authors: Bufalino
authors: Fernando
authors: F
authors: Costa
authors: Larry B
authors: LB
authors: Goldstein
authors: Dan
authors: D
authors: Jones
authors: Lynn
authors: L
authors: Smaha
authors: Sidney C
authors: SC
authors: Smith
authors: Neil
authors: N
authors: Stone
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000378:metabolism / Q000627:therapeutic use*; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists; D016540:Smoking Cessation; D020521:Stroke / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000451:Mineralocorticoid Receptor Antagonists